Skip to content
The Kids Research Institute Australia logo
Donate

No results yet

Search

Showing results for "1"

News & Events

Donated pump a blessing for Kye

Looking at him now, it’s hard to believe busy one-year-old toddler Kye Gilbert was extremely unwell in Perth Children’s Hospital’s critical care unit with a new diagnosis of type 1 diabetes just a few months ago.

Research

The Cost of Control: Cost-effectiveness Analysis of Hybrid Closed-Loop Therapy in Youth

Hybrid closed-loop (HCL) therapy is an efficacious management strategy for young people with type 1 diabetes. However, high costs prevent equitable access. We thus sought to evaluate the cost-effectiveness of HCL therapy compared with current care among young people with type 1 diabetes in Australia.

News & Events

Latitudinal gradient in childhood diabetes

New research from Perth's The Kids Research Institute Australia has shown the local relevance of a worldwide pattern of increased risk of childhood type 1 diabetes.

News & Events

Being active is key to heart health

Did you know that regular exercise can literally add years to the lives of children living with Type 1 Diabetes?

WAACHS Regional Profiles

The WAACHS regional profiles look at all four volumes of results across the ATSIC regions of Western Australia.

News & Events

Let's Talk Diabetes

A diabetes community session with a focus on healthy children.

Research

Interchangeability, immunogenicity and safety of a combined 10-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine (Synflorix) and 13-valent-PCV (Prevenar13) schedule at 1-2-4-6 months: PREVIX_COMBO, a 3-arm randomised controlled trial

Aboriginal children living in remote communities are at high risk of early and persistent otitis media. Streptococcus pneumoniae and non-typeable Haemophilus influenzae (NTHi) are primary pathogens. Vaccines with potential to prevent early OM have not been evaluated in this population. We compared immunogenicity (ELISA and opsonophagocytic activity) of a combination of Synflorix™ (PHiD-CV10, 10 serotypes and protein D of NTHi) and Prevenar13™ (PCV13, 10 serotypes plus 3, 6A, and 19A), with recommended schedules.

News & Events

Local researchers lead biggest ‘artificial pancreas’ outpatient study

The Children’s Diabetes Centre at The Kids Research Institute Australia is leading the longest and largest at-home trial of a hybrid closed-loop insulin pump system.

Research

Cyberbullying and the role of the law in Australian schools: Views of senior officials

Opinions of employees from the education and legal systems, regarding their perceptions of the role of the law and cyberbullying in Australian schools

Research

Use of Hybrid Closed Loop therapy in hypoglycaemia awareness

This study will tell us if the use of a hybrid closed loop system can improve awareness of hypoglycaemia.